SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001654954-24-015262
Filing Date
2024-12-09
Accepted
2024-12-09 07:59:38
Documents
1
Period of Report
2024-12-09

Document Format Files

Seq Description Document Type Size
1 NUCALA COPD SUBMISSION ACCEPTED BY US FDA a2715p.htm 6-K 62272
  Complete submission text file 0001654954-24-015262.txt   63437
Mailing Address 79 NEW OXFORD STREET LONDON X0 WC1A 1DG
Business Address 79 NEW OXFORD STREET LONDON X0 WC1A 1DG 011442080475000
GSK plc (Filer) CIK: 0001131399 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-15170 | Film No.: 241533880
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)